skin disease: Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
399 |
4. Check minimum number of eventsNone |
399 |
5. Include endpointsNone |
399 |
6. Filter based on genotype QC (FinnGen only) |
399 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L90
- Name in latin
- Striae atrophicae
Similar endpoints
↥List of similar endpoints to
Striae atrophicae
based on the number of shared cases.
Similar with more cases:
- Atrophic disorders of skin
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2553 | 1773 | 764 |
| Only index persons | 2451 | 1722 | 729 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.02 |
| Only index persons | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 34.96 | 37.84 | 28.31 |
| Only index persons | 35.09 | 37.92 | 28.41 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 399 | 316 | 83 |
| Unadjusted period prevalence (%) | 0.09 | 0.11 | 0.04 |
| Median age at first event (years) | 42.74 | 42.67 | 42.99 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 355
- Matched controls
- 3548
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L90.6
ICD-10 Finland
Striae atrophicae
4503599627370496.0
323.0
350
*
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
138.2
46.0
48
*
ZXE10
NOMESCO Finland
More than one and less than three hours
5.0
44.0
208
780
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
+∞
43.6
41
*
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
50.0
36.9
44
10
ZXE00
NOMESCO Finland
One hour or less
4.2
36.1
224
1022
ZZF00
NOMESCO Finland
Graft of adipose tissue
84.5
34.6
38
5
WX408
NOMESCO Finland
General anesthesy, balanced
4.2
30.8
153
546
QBJ00
NOMESCO Finland
Liposuction in trunk
108.9
28.1
30
*
L91.0
ICD-10 Finland
Hypertrophic scar
58.3
27.7
32
6
ZXE20
NOMESCO Finland
More than three and less than five hours
5.3
27.0
91
215
QBJ30
NOMESCO Finland
Correction of abdominal apron
28.4
26.8
36
14
ZXD10
NOMESCO Finland
Scheduled procedure
3.3
24.9
184
869
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.7
24.1
129
471
ZZA00
NOMESCO Finland
Split skin graft
22.5
21.7
31
15
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.8
21.4
56
95
R4110
NOMESCO Finland
Physiotherapy
3.3
21.3
133
539
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
9.7
20.0
41
47
Z3226
NOMESCO Finland
Physiotherapist
3.6
19.6
105
374
ZXD05
NOMESCO Finland
Urgent procedure
2.9
18.6
155
750
R4120
NOMESCO Finland
Occupational therapy
6.1
17.4
49
91
X59
ICD-10 Finland
Exposure to unspecified factor
3.3
16.7
95
350
Z3231
NOMESCO Finland
Registered nurse
2.8
15.5
127
592
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
4.2
15.2
62
172
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.4
14.3
44
91
Z2221
NOMESCO Finland
Medical doctor
2.6
14.3
135
679
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
145.3
13.5
14
*
N02BE01
ATC
paracetamol; systemic, rectal
3.2
13.5
316
2541
TQW99
NOMESCO Finland
Other minor procedure on skin
8.1
13.5
30
40
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
41.8
13.3
16
*
N02AX02
ATC
tramadol; systemic, rectal
2.4
13.2
156
873
ZXA10
NOMESCO Finland
Bilateral
3.1
13.1
83
322
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.5
12.5
117
576
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.8
12.3
35
66
WX110
NOMESCO Finland
Local anesthesy
2.5
12.1
280
2133
N03AX16
ATC
pregabalin; oral
2.7
12.1
96
430
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
12.0
42
100
J01FF01
ATC
clindamycin; systemic
2.5
11.9
114
564
N62
ICD-10 Finland
Hypertrophy of breast
5.2
11.9
37
78
WX002
NOMESCO Finland
Sedation and analgesia
2.8
11.7
86
367
S18
ICPC
Laceration/cut
2.3
11.5
149
859
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
17.8
11.3
17
10
J01DB01
ATC
cefalexin; oral
2.7
11.0
309
2523
E0000UV
ATC
NA
2.2
10.9
163
994
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.8
10.9
36
81
ZXA05
NOMESCO Finland
Left side
2.5
10.6
96
456
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.2
10.6
141
814
N06AX16
ATC
venlafaxine; oral
2.8
10.5
74
307
N05BA04
ATC
oxazepam; oral
2.4
10.4
103
515
P01AB01
ATC
metronidazole; oral, rectal
2.1
10.2
165
1033
WX402
NOMESCO Finland
General anaesthesia
2.6
10.0
81
361
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
41.3
10.0
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
10.0
58
212
TQW40
NOMESCO Finland
Remowal of suture of skin
4.0
9.9
39
105
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.1
9.9
38
100
N05CF01
ATC
zopiclone; oral
2.3
9.8
113
605
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.0
9.7
26
46
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
3.7
9.6
43
129
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
10.5
9.6
18
18
ZZR00
NOMESCO Finland
Flap of skin
12.8
9.4
16
13
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
9.3
173
1134
J01MA12
ATC
levofloxacin; systemic
2.8
9.3
66
271
A46
ICD-10 Finland
Erysipelas
3.3
9.1
47
158
B01AB05
ATC
enoxaparin; parenteral
2.2
9.1
105
563
N06AB04
ATC
citalopram; systemic
2.3
8.9
92
466
M79.6
ICD-10 Finland
Pain in limb
2.1
8.9
140
855
Z2446
NOMESCO Finland
Social worker
3.7
8.9
39
116
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
7.5
8.9
20
28
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.0
8.8
51
187
L28
ICPC
Limited function/disability (L)
3.0
8.8
51
187
R03AC02
ATC
salbutamol; inhalant
2.0
8.6
203
1442
HAE99
NOMESCO Finland
Other reconstruction of breast
20.6
8.5
12
6
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
92.1
8.4
9
*
QDE30
NOMESCO Finland
Excision and repair of surgical scar in lower limb
+∞
8.4
8
*
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
9.8
8.4
16
17
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
8.3
67
298
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
8.3
132
804
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
7.8
8.3
18
24
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
34.2
8.1
10
*
J01DA01
ATC
[U] cefalexin; systemic
1.9
8.1
232
1752
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.4
7.9
69
319
N06AX11
ATC
mirtazapine; oral
2.0
7.9
117
690
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.6
7.8
35
106
A01
ICPC
Pain general/multiple sites
3.3
7.7
38
124
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.2
7.7
39
130
A08
ICPC
Swelling
5.4
7.7
22
43
E000002
ATC
NA
2.6
7.6
57
244
H02AB06
ATC
prednisolone; systemic
1.9
7.5
160
1073
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.9
7.5
16
21
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.7
7.4
12
9
H02AB09
ATC
hydrocortisone; systemic
7.1
7.4
17
25
N06AB10
ATC
escitalopram; oral
2.1
7.2
91
499
R52.2
ICD-10 Finland
Other chronic pain
5.2
7.2
21
42
N05BA01
ATC
diazepam; systemic, rectal
2.6
7.2
55
237
D06
ICPC
Abdominal pain localized other
3.0
7.2
41
148
TQW20
NOMESCO Finland
Tatoe
8.2
7.2
15
19
A06AD11
ATC
lactulose; oral
2.9
7.1
44
166
S29
ICPC
Skin symptom/complaint other
2.3
7.1
67
324
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.8
7.0
22
48
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.5
7.0
31
94
N05AH04
ATC
quetiapine; oral
2.2
7.0
74
376
E66.8
ICD-10 Finland
Other obesity
3.3
6.9
34
111
E000001
ATC
NA
2.1
6.9
89
491
GBB00
NOMESCO Finland
Tracheostomy
14.1
6.9
11
8
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
6.9
122
764
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.3
6.8
33
107
R05
ICD-10 Finland
Cough
2.2
6.8
71
359
X58
ICD-10 Finland
Exposure to other specified factors
2.4
6.8
62
293
A02BC02
ATC
pantoprazole; systemic
1.8
6.7
217
1655
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.5
6.7
30
92
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
2.4
6.6
55
249
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.8
6.6
208
1568
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
6.6
95
548
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.6
6.6
48
202
R06AE07
ATC
cetirizine; oral
1.8
6.5
169
1196
AA1AD
NOMESCO Finland
CT of head and brain
2.2
6.5
69
351
N03AE01
ATC
clonazepam; systemic
3.7
6.5
27
78
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
71.1
6.4
7
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.4
6.4
30
95
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
6.4
38
142
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
6.8
6.4
15
23
D07AC13
ATC
mometasone; topical
1.9
6.4
103
618
A02BC01
ATC
omeprazole; systemic
2.0
6.3
95
558
ZXA00
NOMESCO Finland
Right side
2.0
6.3
85
479
D07AA02
ATC
hydrocortisone; topical
2.3
6.3
62
305
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
6.3
199
1494
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.6
6.3
46
192
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
6.3
154
1066
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
+∞
6.3
6
*
EDC38
NOMESCO Finland
Open reduction and fixation of fracture of body of mandible
+∞
6.3
6
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
3.7
6.3
26
75
QCB05
NOMESCO Finland
Revision of wound of skin of upper limb
27.2
6.3
8
*
UKC02
NOMESCO Finland
Cystoscopy
2.7
6.2
41
164
R60.0
ICD-10 Finland
Localized oedema
2.8
6.2
39
149
A02BC05
ATC
esomeprazole; systemic
1.8
6.1
138
930
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
6.1
71
376
QAB00
NOMESCO Finland
Suture of skin of head or neck
8.8
6.1
12
14
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
6.1
46
198
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
10.3
6.1
11
11
HA1AA
NOMESCO Finland
X-ray mammography
2.8
6.0
38
146
D07AD01
ATC
clobetasol; topical
2.3
6.0
58
283
TKC20
NOMESCO Finland
Catheterisation of bladder
3.9
6.0
23
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
80
279
3.34
18.56
3.9
2.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
202
1184
2.43
16.83
6.3
4.2
g/l
36.4
36.5
0.15
188
1106
(40761536) Microorganisms panel - Urine sediment
72
286
2.85
13.11
5.3
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
223
1467
2.18
12.97
11.3
8.0
e9/l
0.0
0.0
1.07
186
1193
(3004789) Transferrin [Mass/volume] in Serum or Plasma
86
386
2.57
12.28
2.6
2.2
g/l
2.5
2.4
0.35
76
358
(3012095) Magnesium [Moles/volume] in Serum or Plasma
92
440
2.42
11.41
3.4
3.1
mmol/l
0.8
0.8
0.33
78
414
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
130
723
2.18
11.27
2.6
2.1
mg/l
2.7
2.9
0.66
117
614
(3018418) pH of Serum or Plasma
145
849
2.11
10.95
5.0
3.5
ph
7.4
7.4
0.88
35
149
(3003458) Phosphate [Moles/volume] in Serum or Plasma
72
315
2.57
10.76
6.7
5.0
mmol/l
1.1
1.0
0.63
66
290
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
78
355
2.49
10.73
2.8
2.3
%
23.3
23.7
0.09
69
302
(3022096) Basophils/100 leukocytes in Blood
214
1458
2.01
10.53
6.7
5.6
%
0.7
0.7
0.02
205
1363
(3001604) Monocytes [#/volume] in Blood
231
1617
2.02
10.52
6.6
5.4
e9/l
0.5
0.5
0.10
201
1422
(3006315) Basophils [#/volume] in Blood
232
1629
2.01
10.45
6.6
5.4
e9/l
0.0
0.0
0.94
204
1427
(3015377) Calcium [Moles/volume] in Serum or Plasma
161
1000
2.02
10.22
4.8
3.0
mmol/l
2.3
2.4
0.69
144
892
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
95
487
2.25
9.92
3.0
2.5
mmol/l
2.4
2.4
0.26
82
428
(3042936) Bacteria identified in Isolate by Culture
81
388
2.36
9.91
2.9
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
86
423
2.32
9.90
2.7
2.2
umol/l
14.1
14.2
0.04
77
388
(3019198) Lymphocytes [#/volume] in Blood
235
1683
1.96
9.71
6.5
5.5
e9/l
2.0
2.0
0.02
208
1513
(3006504) Eosinophils/100 leukocytes in Blood
218
1523
1.95
9.69
6.7
5.4
%
2.9
2.8
0.44
209
1424
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
65
4.21
9.66
2.8
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
219
1535
1.95
9.61
6.9
5.7
%
8.1
8.1
0.01
210
1448
(3002030) Lymphocytes/100 leukocytes in Blood
224
1588
1.94
9.44
6.8
5.5
%
29.9
29.2
0.52
212
1493
(3000850) Epithelial cells [#/volume] in Urine
107
590
2.11
9.24
3.7
2.2
e6/l
7.8
7.8
0.00
97
526
(42870588) Differential panel, method unspecified - Blood
158
1007
1.94
9.07
6.2
5.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
238
1741
1.91
8.91
4.8
4.3
mmol/l
6.2
6.4
0.73
224
1583
(3013115) Eosinophils [#/volume] in Blood
233
1693
1.90
8.90
6.8
5.9
e9/l
0.2
0.2
0.21
209
1513
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
169
1109
1.91
8.83
2.1
1.8
pmol/l
98.2
97.9
0.03
94
562
(3002256) Pathology report gross observation
78
386
2.27
8.79
1.4
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
220
1576
1.88
8.72
6.5
5.3
%
56.1
56.7
0.32
210
1487
(3013650) Neutrophils [#/volume] in Blood by Automated count
252
1894
1.90
8.51
9.6
8.7
e9/l
4.0
4.0
0.15
225
1666
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
218
1568
1.86
8.42
7.3
5.5
umol/l
9.1
10.3
1.72
208
1484
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
301
2419
1.99
8.07
9.6
6.6
u/l
74.4
74.1
0.05
287
2260
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
156
1024
1.86
7.95
4.5
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
129
797
1.91
7.93
4.5
2.7
e6/l
0.2
0.4
1.21
94
587
(3026782) Osmolality of Urine
100
568
2.01
7.84
3.9
2.4
mosm/kgh2o
509.4
550.0
1.06
88
488
(3001122) Ferritin [Mass/volume] in Serum or Plasma
224
1653
1.81
7.69
3.9
2.7
ug/l
127.3
86.5
0.55
210
1547
(3032080) INR in Blood by Coagulation assay
149
974
1.85
7.63
7.3
6.2
inr
1.1
1.1
0.14
61
315
(3007853) Bacteria identified in Skin by Aerobe culture
67
331
2.23
7.53
2.0
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
127
793
1.88
7.49
6.8
6.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
152
1006
1.83
7.44
2.9
2.0
—
—
—
0
0
(3044889) 12 lead EKG panel
268
2102
1.84
7.38
3.9
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
137
882
1.84
7.31
4.7
2.8
e6/l
60.9
47.4
0.12
106
663
(3023368) Bacteria identified in Blood by Culture
109
654
1.92
7.23
5.2
3.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
83
455
2.04
7.12
2.2
1.6
nmol/l
1338.3
1147.5
1.01
64
350
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
48
213
2.42
6.88
4.8
3.4
mmol/l
1.2
1.2
0.51
40
179
(3023323) Follitropin [Units/volume] in Serum or Plasma
54
253
2.31
6.86
1.4
1.3
iu/l
28.1
25.7
0.18
45
212
(36304419) Bacteria [Presence] in Urine
125
799
1.82
6.74
4.0
2.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
130
842
1.81
6.70
1.5
1.6
mmol/l
1.4
1.4
0.49
105
740
(3002385) Erythrocyte distribution width [Ratio]
342
2942
2.14
6.69
22.0
13.6
%
13.6
13.5
0.51
337
2891
(3012501) Base excess in Blood by calculation
19
51
3.86
6.44
4.5
1.9
mmol/l
2.0
2.7
0.65
13
35
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
176
1256
1.72
6.41
6.7
5.4
mmol/l
1.2
1.2
0.24
158
1153
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
190
1385
1.71
6.40
7.4
6.2
mmol/l
1.2
1.2
0.43
151
1180
(3002179) Metamyelocytes/100 leukocytes in Blood
49
228
2.31
6.32
4.2
3.9
%
0.2
0.5
0.91
11
50
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
320
2710
1.91
6.25
5.5
4.0
pmol/l
14.5
14.5
0.12
298
2499
(3027945) Reticulocytes/100 erythrocytes in Blood
52
250
2.24
6.21
1.8
2.8
%
1.7
1.7
0.07
45
221
(40768804) Tissue Pathology biopsy report
184
1340
1.69
6.15
2.3
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
158
1106
1.71
6.10
5.2
3.3
e6/l
51.4
69.4
0.34
109
730
(3000991) Gas panel - Venous blood
45
206
2.34
6.02
6.0
7.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
56
282
2.15
5.97
2.3
2.2
u/l
29.3
32.3
0.29
50
235
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
353
3107
2.18
5.97
15.8
9.8
ml/min/173m2
90.3
89.1
0.46
312
2508
(3007164) IgA [Mass/volume] in Serum or Plasma
119
783
1.74
5.68
1.5
1.4
g/l
2.1
2.2
0.54
67
480
(1616796) Gas panel - Central venous blood
16
42
3.93
5.59
3.1
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
41
188
2.32
5.47
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
98
620
1.77
5.32
1.7
1.5
nmol/l
20.1
21.8
0.63
87
540
(3052851) Hemolysis interference index of Serum or Plasma
23
80
2.99
5.28
2.9
3.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
112
742
1.71
5.15
2.0
1.7
mg/l
1.3
0.9
0.57
77
557
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
354
3162
2.06
5.07
6.2
4.7
mu/l
1.7
1.8
0.85
344
2946
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
372
3389
2.44
5.04
18.5
11.0
mg/l
20.7
20.1
0.13
309
2544
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
181
1362
1.60
5.01
3.0
2.3
nmol/l
74.8
75.1
0.05
168
1243
(3017181) Myelocytes/100 leukocytes in Blood
50
261
2.05
4.85
4.2
4.1
%
0.6
0.9
0.53
14
84
(3021788) Differential panel - Synovial fluid
14
37
3.89
4.85
1.8
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
273
2277
1.63
4.83
5.3
3.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
120
824
1.65
4.78
5.4
4.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
365
3313
2.19
4.76
18.8
11.7
mmol/l
3.9
3.9
0.43
355
3202
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
500
1.78
4.75
3.4
3.2
ng/l
257.2
300.4
0.06
55
315
(3021901) Oxygen saturation in Capillary blood
13
33
4.04
4.75
1.5
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
242
2.07
4.73
4.4
4.3
%
0.0
0.1
1.94
14
71
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
129
906
1.63
4.68
1.4
1.3
u/ml
1.0
2.2
0.76
32
242
(3025159) Blasts/100 leukocytes in Blood
45
229
2.09
4.67
4.5
4.3
%
0.0
0.2
0.65
11
58
(3019550) Sodium [Moles/volume] in Serum or Plasma
364
3305
2.16
4.66
18.6
11.6
mmol/l
139.6
139.6
0.27
356
3206
(40767503) Oxygen content in Capillary blood by calculation
15
43
3.59
4.66
3.6
1.9
%
17.6
15.9
—
8
18
(3025941) Bacteria identified in Stool by Culture
42
210
2.12
4.57
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
198
1562
1.53
4.23
5.6
3.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
40
203
2.08
4.19
3.8
3.9
ng/l
82.0
71.2
0.45
32
181
(3017143) Hepatitis C virus Ab [Presence] in Serum
77
485
1.73
4.18
1.5
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
42
221
2.01
4.00
3.6
3.5
mmol/l
2.3
1.9
0.28
34
172
(3020961) Endomysium IgA Ab [Titer] in Serum
39
200
2.05
3.98
1.1
1.1
—
195.0
—
0
6
(3023520) Reticulocytes [#/volume] in Blood
34
166
2.15
3.94
2.3
2.9
e9/l
69.7
71.3
0.08
22
130
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
115
816
1.58
3.90
2.7
2.0
u/l
148.5
235.9
0.53
108
774
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
16
54
3.04
3.89
3.8
3.1
%
61.3
55.8
0.85
16
54
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
107
756
1.57
3.67
2.8
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
202
1639
1.47
3.55
4.2
3.2
estimate
0.0
0.0
0.00
62
316
(3026008) Bacteria identified in Urine by Culture
126
933
1.51
3.48
3.8
2.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
147
1124
1.49
3.47
4.3
2.9
u/l
47.8
29.5
0.51
142
1078
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
274
2368
1.50
3.45
3.9
2.9
u/l
43.8
39.1
0.55
254
2239
(3009508) Creatinine [Moles/volume] in Urine
117
855
1.52
3.43
4.5
2.9
mmol/l
7.5
7.6
0.09
97
730
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
53
2.90
3.39
3.7
3.0
e9/l
4.5
4.2
0.16
15
53
(3006184) Hemoglobin [Mass/volume] in Capillary blood
15
53
2.90
3.39
1.3
1.9
g/l
134.5
132.4
—
10
34
(3024928) Oxygen saturation in Venous blood
14
48
2.99
3.33
1.6
2.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
200
1636
1.45
3.28
5.9
4.6
estimate
0.0
0.0
0.50
61
317
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
38
3.22
3.24
1.2
1.3
—
—
—
0
0
(3000492) Spirometry study
55
339
1.72
3.22
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
56
348
1.71
3.19
1.5
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
378
3557
2.19
3.19
12.7
8.8
u/l
27.7
25.5
0.44
371
3439
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
226
1.86
3.13
1.1
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
320
2881
1.56
3.12
5.3
4.7
mmol/mol
37.6
38.5
1.05
305
2713
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
119
890
1.48
3.08
1.8
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
201
1660
1.42
3.06
4.3
3.3
estimate
0.0
0.0
0.00
58
309
(3015736) pH of Urine
162
1287
1.44
3.05
3.6
3.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
64
2.56
2.91
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
67
447
1.60
2.91
3.9
2.7
e6/l
3.8
3.3
0.13
34
226
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
41
2.99
2.88
2.0
1.4
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
18
4.51
2.81
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
22
104
2.18
2.80
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
22
104
2.18
2.80
1.1
1.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
23
3.98
2.79
1.2
1.4
umol/l
8.5
9.5
—
9
23
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
69
469
1.57
2.77
3.9
2.4
e6/l
1.1
0.9
0.20
36
246
(3022145) Colonoscopy Study observation
57
370
1.63
2.76
1.2
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
6
8.42
2.75
1.8
3.5
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
55
2.60
2.64
1.1
1.2
u/ml
3.3
4.8
—
6
26
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
38
2.95
2.60
1.2
1.3
nmol/l
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
377
3576
1.98
2.58
15.8
10.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
15
62
2.47
2.57
6.4
3.0
u/ml
51.3
30.4
0.37
15
62
(40768797) Stomach Pathology biopsy report
60
402
1.58
2.56
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
14
56
2.55
2.56
1.9
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
14
56
2.55
2.56
1.9
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
102
2.12
2.52
1.3
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
35
204
1.78
2.51
3.5
1.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
16
4.43
2.48
2.3
2.4
u/ml
602.4
408.0
—
7
16
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
57
2.51
2.47
1.7
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
31
175
1.84
2.46
3.8
1.9
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
24
124
2.00
2.46
1.2
1.3
u/l
13.8
10.5
0.41
19
97
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
117
2.02
2.46
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
10
34
2.99
2.43
1.3
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
214
1.75
2.42
2.3
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
15
64
2.40
2.41
1.5
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
6
12
5.06
2.41
2.3
1.5
umol/l
23.5
28.4
—
6
12
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
79
570
1.48
2.41
2.5
1.6
pmol/l
465.9
430.1
0.66
63
495
(3048689) Calprotectin [Mass/mass] in Stool
69
484
1.51
2.41
2.6
2.4
ug/g
132.2
93.3
0.71
51
377
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
254
1.68
2.39
2.1
2.2
u/l
3098.0
2893.5
—
7
111
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
16
71
2.31
2.37
1.1
1.3
—
—
—
0
0
(4094501)
16
71
2.31
2.37
1.1
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
123
966
1.40
2.37
4.4
2.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
32
186
1.78
2.32
1.5
1.6
mu/l
247.2
282.3
0.56
26
164
(3028271) Lactate [Moles/volume] in Capillary blood
10
35
2.90
2.32
4.5
1.7
mmol/l
1.8
1.7
—
10
35
(3027008) Opiates [Presence] in Urine
36
217
1.72
2.31
3.4
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
218
1.72
2.28
3.4
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
49
322
1.59
2.28
1.2
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
66
2.32
2.27
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
36
219
1.71
2.24
3.4
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
13
54
2.45
2.22
1.8
3.2
kpa
9.6
8.1
1.86
13
48
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
10
36
2.82
2.21
1.1
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
20
101
2.03
2.19
4.8
2.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
125
996
1.37
2.19
2.9
3.1
ng/l
37.2
39.4
0.04
65
561
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
120
950
1.38
2.18
3.1
2.3
u/l
61.1
54.9
0.54
114
879
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
9
30
3.05
2.16
1.3
2.5
nmol/l
3.1
4.0
—
9
30
(4281824)
9
30
3.05
2.16
1.1
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
19
3.73
2.16
1.1
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
272
2444
1.35
2.11
5.4
3.7
mm/h
11.7
9.8
1.28
249
2263
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
288
1.59
2.09
2.2
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
132
1.87
2.08
1.7
1.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
67
484
1.46
2.03
1.5
1.4
titre
414.3
523.9
0.38
14
102
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
43
283
1.58
2.00
2.1
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
26
149
1.80
2.00
1.7
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
47
317
1.55
1.97
1.2
1.2
iu/ml
195.3
160.2
0.16
13
141
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
45
2.49
1.94
4.6
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
251
0.46
1.94
1.3
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
292
2668
1.35
1.92
3.9
3.6
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
22
3.22
1.89
1.3
1.6
%
11.4
11.6
—
7
22
(3020630) Protein [Mass/volume] in Serum or Plasma
30
183
1.69
1.88
1.8
2.7
g/l
66.8
67.2
0.12
30
171
(3023419) Bacteria identified in Sputum by Culture
8
28
2.89
1.87
1.6
2.6
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
12
4.20
1.83
1.4
2.9
nmol/l
61.6
113.1
—
5
12
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
23
131
1.80
1.82
1.6
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
7
23
3.08
1.80
1.0
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
41
2.48
1.77
1.4
6.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
18
3.37
1.75
3.0
4.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
36
2.53
1.75
1.7
1.3
—
—
—
0
0
(4306422)
11
48
2.33
1.72
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
57
413
1.44
1.71
2.2
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
12
55
2.22
1.69
1.8
5.5
mg/l
26.7
28.0
—
6
45
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
142
1.73
1.69
2.3
3.4
mmol/l
2.4
1.7
0.43
16
107
(4035726)
37
246
1.56
1.67
1.4
1.4
—
—
—
0
0
(4062490)
8
31
2.61
1.66
1.5
1.3
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
8
31
2.61
1.66
1.9
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
340
3205
1.41
1.66
20.2
11.9
%
40.2
40.2
0.01
279
2564
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
8
32
2.53
1.60
1.5
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
346
3280
1.41
1.55
4.6
4.2
mmol/l
2.8
2.9
0.14
332
3073
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
66
501
1.38
1.54
2.4
1.8
%
1.6
1.4
1.18
56
455
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
86
1.90
1.52
1.4
1.3
ug/g
341.7
325.6
—
10
48
(4268621)
9
37
2.46
1.49
1.8
2.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
38
2.40
1.46
1.1
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
52
2.15
1.45
1.1
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
13
66
2.00
1.45
1.3
1.4
u/ml
115.9
114.5
—
5
15
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
28
181
1.59
1.44
1.8
1.7
mg/l
2.4
3.0
0.32
21
129
(21494755) Public health laboratory ask at order entry panel
33
476
0.67
1.44
1.3
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
16
3.15
1.44
1.0
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
81
1.89
1.42
1.7
2.4
g/l
3.1
3.1
0.09
15
71
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
29
2.44
1.40
2.6
2.0
pg
32.0
33.3
—
7
29
(3000475) Leukocytes [#/volume] in Synovial fluid
11
53
2.11
1.39
2.0
1.4
e6/l
3168.6
23101.7
—
5
38
(3009343) pH of Capillary blood
24
151
1.63
1.38
2.3
3.3
ph
7.4
7.4
—
9
11
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
24
151
1.63
1.38
2.3
3.3
kpa
5.2
5.2
0.05
24
142
(3042631) Mycobacterium sp identified in Specimen
6
23
2.63
1.37
2.2
2.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
105
869
1.28
1.36
4.6
3.4
estimate
0.0
0.0
0.50
61
319
(3011288) Drugs identified in Urine by Screen method
25
160
1.60
1.35
5.1
2.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
9
42
2.17
1.34
1.1
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
83
1.84
1.33
1.7
2.4
g/l
9.3
10.0
0.40
15
78
(3021879) Hepatitis B virus core Ab [Presence] in Serum
41
294
1.44
1.33
1.3
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
114
956
1.27
1.33
2.0
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
332
3146
1.33
1.32
4.4
3.8
mmol/l
5.7
5.7
0.11
318
2909
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
9
43
2.12
1.31
1.6
2.9
u/ml
3.3
103.2
—
9
37
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
130
1.65
1.29
1.0
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
130
1.65
1.29
1.7
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
25
162
1.58
1.29
2.3
2.0
nmol/l
7.3
12.3
1.61
19
145
(3034860) Kappa light chains.free [Mass/volume] in Serum
11
55
2.03
1.28
1.8
5.5
mg/l
23.8
39.9
—
5
45
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
35
2.31
1.27
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
13
70
1.89
1.25
2.2
2.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
25
2.42
1.25
3.0
4.0
—
—
—
0
0
(4027681)
6
25
2.42
1.25
1.5
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
712
1.28
1.23
3.4
3.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
19
2.65
1.22
2.4
7.7
—
—
—
0
0
(3013512) EKG study
94
779
1.27
1.20
2.8
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
26
2.33
1.19
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
26
2.33
1.19
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
340
3245
1.32
1.19
4.2
3.8
mmol/l
4.7
4.8
0.45
329
3057
(3004588) Protein electrophoresis panel - Serum or Plasma
22
142
1.58
1.17
1.7
2.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
2.3
1.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
20
2.52
1.15
1.6
1.3
u/field
2.2
10.4
—
5
13
(3026361) Erythrocytes [#/volume] in Blood
389
3808
1.86
1.13
26.2
16.5
e12/l
4.5
4.5
0.61
384
3720
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
88
1.73
1.13
1.7
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
88
1.73
1.13
1.7
2.3
g/l
3.9
3.7
0.22
15
70
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
88
1.73
1.13
1.7
2.3
g/l
7.5
7.4
0.08
15
72
(3016244) Insulin [Units/volume] in Serum or Plasma
7
30
2.36
1.13
2.4
3.4
mu/l
29.7
19.7
—
7
30
(44816559) Phosphatidylethanol [Mass/volume] in Blood
13
73
1.81
1.12
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
66
1.84
1.10
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
21
2.40
1.09
1.0
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
11
59
1.89
1.08
1.1
1.1
u/ml
0.4
2.7
—
6
16
(3010813) Leukocytes [#/volume] in Blood
389
3811
1.83
1.08
26.3
16.5
e9/l
6.8
6.7
0.46
384
3719
(3014765) Yersinia sp identified in Stool by Organism specific culture
18
113
1.62
1.07
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
35
255
1.41
1.07
4.5
4.0
ug/l
3.5
24.8
0.67
26
206
(3003396) Base excess in Arterial blood by calculation
36
264
1.40
1.06
8.0
8.6
mmol/l
0.3
1.3
0.95
28
208
(3026493) Urate [Moles/volume] in Serum or Plasma
88
735
1.25
1.06
2.0
2.5
umol/l
324.0
7826.7
3.78
77
651
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
106
1.63
1.04
5.4
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
18
114
1.61
1.04
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
75
1.76
1.04
1.4
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
22
2.29
1.03
1.6
1.8
g/l
0.8
1.0
—
5
22
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
22
2.29
1.03
1.2
1.5
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
47
1.94
1.02
2.0
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
53
1.91
1.02
1.8
5.4
—
3.6
—
0
6
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
325
3101
1.26
1.01
3.8
3.4
mmol/l
1.2
1.2
0.02
308
2904
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
224
1.42
1.00
1.5
1.2
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
14
84
1.69
0.99
1.4
1.3
mg/l
494.8
405.8
0.37
14
76
(3019150) Specific gravity of Urine by Refractometry
59
726
0.78
0.98
2.9
3.5
kg/l
1.0
1.0
—
6
95
(40761535) Cells panel - Urine sediment
14
221
0.62
0.96
5.1
3.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
13
77
1.71
0.96
1.2
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
27
2.24
0.94
1.3
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
70
1.74
0.93
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
54
432
1.29
0.92
2.4
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
219
1.40
0.92
1.9
2.5
ml/min/173m2
73.8
75.4
0.09
11
94
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
336
3228
1.26
0.91
4.2
3.8
mmol/l
1.5
1.5
0.02
319
3030
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
6
29
2.08
0.89
1.8
2.3
u/field
0.7
2.6
—
6
11
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
29
2.08
0.89
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
787
1.22
0.89
1.6
1.7
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
15
95
1.60
0.88
1.3
1.3
—
56.3
—
0
8
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
43
336
1.31
0.88
2.5
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
43
1.88
0.88
1.5
1.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
30
2.01
0.87
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
112
1.54
0.86
1.4
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
84
715
1.22
0.86
4.8
3.1
mg/l
71.8
163.8
0.42
55
436
(3022217) INR in Platelet poor plasma by Coagulation assay
37
284
1.33
0.85
22.5
15.9
inr
1.3
1.2
—
9
50
(3002523) Influenza virus A Ag [Presence] in Specimen
14
88
1.61
0.85
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
14
88
1.61
0.85
1.1
1.1
—
—
—
0
0
(44813793)
6
31
1.95
0.84
1.0
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
45
1.79
0.84
1.9
1.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
65
1.71
0.83
1.3
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
15
97
1.57
0.82
1.5
1.7
iu/ml
0.0
0.0
—
7
17
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
73
1.66
0.82
1.3
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
47
1.72
0.81
1.5
1.5
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
21
148
1.44
0.79
6.0
2.4
e6/l
0.1
0.1
0.86
21
143
(3037121) Protein [Mass/volume] in Urine
15
98
1.55
0.79
2.5
3.1
g/l
0.4
0.2
—
8
39
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.3
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
34
1.78
0.76
1.3
1.3
pmol/l
208.8
395.8
—
6
29
(3019225) pH of Specimen
18
254
0.69
0.76
6.3
3.7
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
24
2.10
0.74
1.2
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
24
2.10
0.74
1.8
1.2
mmol/l
1.8
1.9
—
5
24
(40768795) Lymph node Pathology biopsy report
5
25
2.01
0.73
1.2
1.0
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
5
25
2.01
0.73
1.0
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
12
76
1.60
0.72
1.1
1.1
u/ml
0.2
0.7
—
7
31
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
141
1277
1.16
0.71
4.6
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
26
1.93
0.71
1.2
1.5
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
21
152
1.40
0.70
8.9
8.3
%
94.6
94.2
0.12
21
152
(1761868) Lipid panel - Serum or Plasma
145
1321
1.15
0.68
3.0
2.4
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
13
86
1.53
0.67
2.7
1.6
ug/l
0.5
4.3
0.66
13
80
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
28
359
0.76
0.67
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
233
1.31
0.67
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
180
1.35
0.66
2.3
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
76
658
1.19
0.66
2.5
2.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
28
1.80
0.66
1.2
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
12
78
1.56
0.66
1.9
2.1
mg/l
10.4
10.6
0.05
12
70
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
621
1.19
0.66
3.2
3.1
ng/l
906.4
950.8
0.06
59
508
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
212
0.70
0.65
1.5
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
29
225
1.31
0.65
2.2
2.4
u/ml
21.7
42.8
1.03
29
218
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
83
727
1.18
0.64
2.5
2.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
323
0.76
0.63
7.8
5.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
50
1.61
0.61
5.1
4.1
—
195.3
—
0
6
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
53
1.52
0.58
1.4
2.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
35
1.72
0.58
1.0
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
85
753
1.16
0.57
6.7
3.8
mg/mmol
10.6
10.3
0.02
53
460
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
11
74
1.50
0.54
1.1
1.2
mmol/l
3.5
3.6
0.14
11
66
(3023410) Appearance of Cerebral spinal fluid
6
39
1.55
0.53
1.0
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
15
203
0.73
0.53
2.9
2.8
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
12
83
1.46
0.52
1.2
1.4
ug/l
1.9
3.0
0.94
12
74
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
168
0.71
0.51
1.1
1.4
—
—
—
0
0
(1002224) Polysomnography panel
21
162
1.31
0.51
1.1
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
201
0.74
0.50
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
201
0.74
0.50
1.3
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
110
1.38
0.49
1.1
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
45
1.57
0.49
1.3
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
200
0.74
0.49
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
200
0.74
0.49
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
13
93
1.41
0.48
6.6
4.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
11
154
0.71
0.48
1.2
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
47
1.50
0.48
3.6
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
13
94
1.40
0.46
1.2
1.1
u/ml
1.7
2.1
—
8
32
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
11
151
0.72
0.43
1.7
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
222
1.23
0.42
2.9
2.8
ug/l
0.5
0.8
1.82
17
115
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
566.1
—
0
9
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
44.2
—
0
9
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
296.1
—
0
9
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
1644.2
—
0
17
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
8
60
1.34
0.40
2.5
2.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
148
0.74
0.39
2.1
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
66
1.37
0.38
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
66
1.37
0.38
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
87
797
1.12
0.37
1.7
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
394
0.85
0.36
1.4
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
168
0.77
0.36
1.5
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
71
1.27
0.36
2.3
1.8
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
13
100
1.31
0.34
1.8
1.9
iu/l
1.9
5.7
—
6
37
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.0
1.5
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
7
54
1.30
0.30
1.6
2.0
%
13.3
13.1
—
7
54
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
281
0.84
0.30
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
17
141
1.21
0.26
7.4
2.5
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
169
1.19
0.26
1.3
1.3
miu/ml
153.9
249.9
0.80
12
89
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
72
0.69
0.26
4.0
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
75
0.66
0.26
1.4
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
18
151
1.20
0.25
1.4
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
77
1.17
0.24
7.9
3.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
33
294
1.13
0.24
4.4
4.0
%
14.2
22.0
3.21
11
115
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
39
1.29
0.23
1.0
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
40
1.25
0.22
1.6
1.5
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
114
1086
1.07
0.22
1.6
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
10.0
—
0
11
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.7
—
228.9
—
0
10
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
101
0.79
0.21
2.1
1.7
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
13
0.00
0.21
0.0
12.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
14
165
0.84
0.20
1.4
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
50
1.20
0.20
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
14
118
1.19
0.19
11.5
12.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
10
81
1.24
0.19
1.1
1.2
—
38.2
—
0
7
(3005033) Fetal Nuchal fold Thickness US
14
164
0.85
0.18
1.4
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
69
0.72
0.17
1.4
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
139
1.16
0.16
8.1
7.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
9
107
0.84
0.13
2.1
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
15
169
0.88
0.13
1.4
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
597
0.95
0.11
1.4
1.3
u/ml
1.9
12.1
4.01
23
240
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
15
167
0.89
0.11
1.5
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
203
1.09
0.10
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
114
0.87
0.09
2.5
3.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
267
0.93
0.08
2.0
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
137
1.10
0.07
2.2
2.2
—
—
—
0
0
(4034850)
9
103
0.87
0.06
16.6
8.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
61
625
0.97
0.05
1.3
1.3
iu/ml
15.7
29.4
1.51
12
210
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
10
91
1.10
0.04
1.7
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
22
228
0.96
0.02
1.6
2.2
e9/l
4.6
4.1
0.45
17
192
(3019832) Treponema pallidum Ab [Presence] in Serum
60
608
0.98
0.01
1.9
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
52
513
1.02
0.01
1.6
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
136
0.95
0.00
2.2
1.6
—
—
—
0
0
(4010399)
21
209
1.01
0.00
1.7
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
125
1.04
0.00
1.2
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
9
0.00
0.00
0.0
5.3
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
450
1.00
0.00
2.2
1.9
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
29.7
—
0
5
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
9
91
0.99
0.00
1.3
1.2
—
3.2
—
0
12
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.0
—
0
6
(3014051) Protein [Presence] in Urine by Test strip
6
66
0.91
0.00
3.5
1.8
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
63
0.95
0.00
1.3
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_STRIAEATROPHICAE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_STRIAEATROPHICAE | 1.328 [1.01, 1.75] | 0.045 |
| Birth year | 0.996 [0.99, 1.0] | 0.317 |
During the follow-up period (1.1.1998 — 31.12.2019), 72 out of 1519 females with L12_STRIAEATROPHICAE died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have L12_STRIAEATROPHICAE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.137% | No data |
| 5 | 0.764% | No data |
| 10 | 1.961% | No data |
| 15 | 3.999% | No data |
| 20 | 7.169% | No data |
Relationships between endpoints
↥Index endpoint: L12_STRIAEATROPHICAE – Striae atrophicae
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data